DRC医薬株式会社
1 known investors
DRC Pharmaceutical develops Hydro Silver Titanium, a proprietary clean technology that decomposes proteins into water, carbon dioxide, and nitrogen. The company produces soft gauze masks and other consumer hygiene products based on this technology.